Sirtex can't explain share surge
Tuesday, 23 August, 2005
Sirtex Medical (ASX:SRX) has been asked by the ASX to explain why its share price soared from $1.90 on August 15 to $2.45 on August 22.
The company responded to the speeding ticket by saying that it is unaware of any information that has not been announced which could explain the recent trading.
Sirtex also indicated that while its financial results have not yet been audited or considered by the directors, based on its draft financial statements the company's operating loss before abnormal items and tax will be greater by more than 15 per cent for the year ended June 30, 2005 than the loss it suffered in the previous corresponding year.
At the time of writing, Sirtex shares were trading at $2.29.
Oxytocin analogue treats chronic abdominal pain
Researchers have developed a new class of oral painkillers to suppress chronic abdominal pain,...
'Low-risk' antibiotic linked to rise of dangerous superbug
A new study has challenged the long-held belief that rifaximin — commonly prescribed to...
Robotic hand helps cultivate baby corals for reef restoration
The soft robotic hand could revolutionise the delicate, labour-intensive process of cultivating...
